Written by:
Dr. Sophie Reynolds
Dr. Sophie Reynolds is a board-certified medical doctor specializing in internal medicine. With over a decade of experience in patient care and medical writing
Cacit 500 mg Tablet
Please fill in the details below, and we’ll get back to you as soon as possible
Similar Products:
| Image | Product | Manufacturer / Marketed By | Price |
|---|---|---|---|
![]() | Capegard 500 mg Tablet | Cipla | Ask for Price |
![]() | Capixet 500 mg Tablet | Everest Pharma | Ask for Price |
Description
Cacit 500mg Tablets are manufactured by Zydus oncosciences in India and contain 500mg of Capecitabine per tablet. Each Blister pack includes 10 x 10 Tablets, making Cacit 500mg Tablets an effective option for Vitamins . Prescription Required from your healthcare provider to purchase Capecitabine medicine. Indogenmed deals in all type of generic Capecitabine medicine.
Benefits
-
Oral alternative to IV chemotherapy (5-FU)
-
Effective in treating breast and gastrointestinal cancers
-
Can be combined with other agents for enhanced effectiveness
-
Flexible outpatient administration
-
Often used in neoadjuvant or adjuvant therapy settings
Indications and Usage
Cacit (Capecitabine) is indicated for the treatment of:
-
Metastatic breast cancer, alone or in combination with docetaxel
-
Colorectal cancer, including Dukes’ C colon cancer and metastatic colorectal cancer
-
Adjuvant therapy following surgery in colon cancer
-
In combination with platinum agents or radiation in gastric cancer (off-label in some regions)
Use only under the supervision of a medical oncologist.
How it Works
Capecitabine is converted in the body to 5-fluorouracil (5-FU), which disrupts DNA synthesis in rapidly dividing cancer cells. This leads to reduced tumor growth and cell death.
Dosage & Administration
-
Dose is calculated by the oncologist based on body surface area (BSA)
-
Typically taken twice daily, within 30 minutes after a meal
-
Swallow tablet whole with water
-
Treatment is often given in cycles (e.g., 14 days on, 7 days off)
-
Do not alter the dose or stop treatment without medical guidance
-
Close monitoring of blood counts and liver function is essential
Side Effects
Common side effects:
-
Hand-foot syndrome (palmar-plantar erythrodysesthesia)
-
Diarrhea
-
Nausea or vomiting
-
Fatigue
-
Loss of appetite
-
Mouth sores
-
Skin rash
Serious side effects (seek medical attention):
-
Severe diarrhea or dehydration
-
Liver function changes
-
Low blood cell counts (anemia, leukopenia)
-
Chest pain or heart rhythm changes
-
Severe hand-foot syndrome
-
Bleeding or infection
Warning and Precaution
-
Not recommended in pregnancy or breastfeeding
-
Use with caution in patients with kidney or liver impairment
-
Avoid alcohol, acidic/spicy foods during treatment
-
Inform your doctor of any chest pain, persistent vomiting, or signs of infection
-
Caution when driving — may cause fatigue or dizziness
-
Do not crush or chew tablets
Related Products
Related Posts:
Ruxolitinib Tablets Receive FDA Approval for Hematologic Malignancies
The U.S. Food and Drug Administration (FDA) has approved Ruxolitinib tablets for the treatment of certain hematologic malignancies, marking another
READ MORE »Tovorafenib Approved in Europe for Children with BRAF-Altered Low-Grade Glioma
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on May 14, 2026.n n This marks an important
READ MORE »FDA Approves Vepdegestrant for ER+/HER2–, ESR1-Mutated Breast Cancer: A New Targeted Option
Medical Review: This article was reviewed by Dr. Sophie Reynolds on May 6, 2026. Breast cancer treatment continues to evolve
READ MORE »Only logged in customers who have purchased this product may leave a review.

Reviews
Clear filtersThere are no reviews yet.